Copyright © 2001 by the European Society of Cardiology.
Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure
Alfred and Baker Medical Unit, Baker Medical Research Institute, Alfred Hospital, Melbourne, Australia
revised August 1, 2000; accepted August 2, 2000
Abstract
Aims To investigate whether strong cardiac sympathetic activity contributes primarily to sudden death or to worsening heart failure, and to determine the relationship of the size of cardiac noradrenaline stores to the mode of death.
Methods and Results The study population comprised 116 patients with congestive heart failure (ejection fraction 19±7%) and a mean follow-up of 18±19 months. Cardiac sympathetic nervous function was measured using coronary sinus blood sampling and noradrenaline isotope dilution methodology. Cardiac sympathetic activity was estimated from cardiac noradrenaline spillover, and noradrenaline stores from the overflow of the tritiated noradrenaline metabolite [3H]dihydroxyphenylglycol, which is produced by monoamine oxidase inside nerve endings. Small cardiac noradrenaline stores (below median) predicted death from worsening heart failure (hazard ratio=4·18, P<0·05), particularly if cardiac noradrenaline spillover was elevated (hazard ratio=2·36 per tertile, P<0·01), indicating progression of disease associated with defective sympathetic innervation. In contrast, large stores (hazard ratio=2·81, P<0·05), especially if coupled with increased noradrenaline spillover (hazard ratio=1·64 per tertile, P<0·05), were related to sudden death.
Conclusion High cardiac sympathetic activity is a risk factor for sudden death, particularly in the presence of intact cardiac sympathetic innervation. Conversely, progression of myocardial disease and heart failure is closely associated with depletion of sympathetic nerves in the heart, especially if rates of noradrenaline release paradoxically remain high.
Key Words: Heart failure • noradrenaline • sympathetic nervous system • prognosis • sudden death
f1 Correspondence: Hans Peter Brunner-La Rocca, MD, Division of Cardiology, Department of Internal Medicine, University Hospital, Rämistrasse 100, 8091 Zurich, Switzerland.
References
- Esler M, Kaye D, Lambert G, Esler D, Jennings G. Adrenergic nervous system in heart failure. Am J Cardiol. 1997;80:7L–14L[CrossRef][Medline]
- Eisenhofer G, Friberg P, Rundqvist B. Cardiac sympathetic nerve function in congestive heart failure. Circulation. 1996;93:1667–1676
[Abstract/Free Full Text] - Bristow MR, Ginsburg R, Minobe W. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med. 1982;307:205–211[Abstract]
- Brodde OE. Beta-adrenoceptors in cardiac disease. Pharmacol Ther. 1993;60:405–430[CrossRef][Web of Science][Medline]
- Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A. Plasma norepinephrine, plasma renin activity and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation. 1993;87:VI40–VI48[Medline]
- Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257–1263[Abstract]
- Lancet. 1999;535:9–13
- Lancet. 1999;353:2001–2007[CrossRef][Web of Science][Medline]
- Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation. 1993;88:136–145
[Abstract/Free Full Text] - Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: Source, fate and functions. Physiol Rev. 1990;70:963–985
[Free Full Text] - Esler, M, Jennings, G, Korner, P, Blombery, P, Sacharias, N, Leonard, P, Measurement of total and organ-specific norepinephrine kinetics in humans, Am J Physiol, 1984, 247, Endocrinol Metab, 10, E21, E28
- Eisenhofer G, Rundqvist B, Friberg P. Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans. Am J Physiol. 1998;274:R626–R634[Medline]
- Eisenhofer G, Goldstein DS, Stull R. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem. 1986;32:2030–2033
[Abstract/Free Full Text] - Eisenhofer G, Meredith IT, Ferrier C. Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. J Lab Clin Med. 1991;117:266–273[Web of Science][Medline]
- La Rovere MT, Bigger JT Jr., Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478–484[CrossRef][Web of Science][Medline]
- Cohn JN, Levine TB, Olivari MT. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–823[Abstract]
- Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activity and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994;23:570–578[Abstract]
- Rundqvist B, Elam M, Bergmann S, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation. 1997;95:169–175
[Abstract/Free Full Text] - Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660–2667
[Abstract/Free Full Text] - Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation. 1996;94:2285–2296
[Abstract/Free Full Text] - Eisenhofer G, Smolich JJ, Esler MD. Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anesthetized dogs. Neurochem Int. 1992;21:37–44[CrossRef][Web of Science][Medline]
- Kaye DM, Esler M, Kingwell B, McPherson G, Esmore D, Jennings G. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation. 1993;88:1110–1118
[Abstract/Free Full Text] - Meredith IT, Esler MD, Cox HS, Lambert GW, Jennings GL, Eisenhofer G. Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clin Auton Res. 1991;1:187–194[CrossRef][Medline]
- Pickrell JW, Abraham WT, Port JD, Roden RL, Bristow MR. Evidence for decreased adrenergic nerve density in the failing human heart. Circulation. 1996;94:I191
- Kaye DM, Vaddadi G, Gruskin SL, Du XJ, Esler MD. Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res. 2000;86:E80–E84[Web of Science][Medline]
- Marley PD, Thomson KA, Bralow RA. Protein kinase A and nicotinic activation of bovine adrenal tyrosine hydroxylase. Br J Pharmacol. 1995;114:1687–1693[Web of Science][Medline]
- N Engl J Med. 1992;327:685–691[Abstract]
- Luu M, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989;80:1675–1680
[Abstract/Free Full Text] - Vermeulen JT. Mechanisms of arrhythmias in heart failure. J Cardiovasc Electrophysiol. 1998;9:208–221[Web of Science][Medline]
- Packer M, Gottlieb SS, Kessler PD. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia. Am J Med. 1986;80:23–29[Web of Science][Medline]
- Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation. 1992;85:I77–I91[Medline]
- Szabo BM, Crijns HJ, Wiesfeld AC, van Veldhuisen DJ, Hillege HL, Lie KI. Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of beta-blockade. Am Heart J. 1995;130:281–286[CrossRef][Web of Science][Medline]
- Molina-Viamonte V, Anyukhovsky EP, Rosen MR. An alpha-1-adrenergic receptor subtype is responsible for delayed afterdepolarizations and triggered activity during simulated ischemia and reperfusion of isolated canine Purkinje fibers. Circulation. 1991;84:1732–1740
[Abstract/Free Full Text] - Lubbe WF, Podzuweit T, Opie LH. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors. J Am Coll Cardiol. 1992;19:1622–1633[Abstract]
- Binah O, Rosen MR. Mechanisms of ventricular arrhythmias. Circulation. 1992;85:I25–I31[Medline]
- Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation. 1994;89:1951–1957
[Abstract/Free Full Text] - Gallo R, Badimon JJ, Fuster V. Pathobiology of coronary ischemic events: clinical implications. Adv Intern Med. 1998;43:203–232[Medline]
- Julius S. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension. 1993;21:886–893
[Free Full Text] - Schwartz PJ, Stone HL. Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction. Circulation. 1980;62:1256–1265
[Abstract/Free Full Text] - Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence for a selective increase in resting cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med. 1991;325:618–624[Abstract]
- Kiowski W, Osswald S. Circadian variation of ischemic cardiac events. J Cardiovasc Pharmacol. 1993;21:S45–S48[Medline]
- Willich SN, Linderer T, Wegscheider K, Leizorovicz A, Alamercery I, Schroder R. Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group. Circulation. 1989;80:853–858
[Abstract/Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Tamaki, T. Yamada, Y. Okuyama, T. Morita, S. Sanada, Y. Tsukamoto, M. Masuda, K. Okuda, Y. Iwasaki, T. Yasui, et al. Cardiac Iodine-123 Metaiodobenzylguanidine Imaging Predicts Sudden Cardiac Death Independently of Left Ventricular Ejection Fraction in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction Results From a Comparative Study With Signal-Averaged Electrocardiogram, Heart Rate Variability, and QT Dispersion. J. Am. Coll. Cardiol., February 3, 2009; 53(5): 426 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Grassi, G. Bolla, F. Quarti-Trevano, F. Arenare, G. Brambilla, and G. Mancia Sympathetic activation in congestive heart failure: Reproducibility of neuroadrenergic markers Eur J Heart Fail, December 1, 2008; 10(12): 1186 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kioka, T. Yamada, T. Mine, T. Morita, Y. Tsukamoto, S. Tamaki, M. Masuda, K. Okuda, M. Hori, and M. Fukunami Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging Heart, October 1, 2007; 93(10): 1213 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jaumdally, C. Varma, R. J. Macfadyen, and G. Y.H. Lip Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment? Eur. Heart J., April 2, 2007; 28(8): 929 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Christ, T. Klima, W. Grimm, H.-H. Mueller, and B. Maisch Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy Eur. Heart J., March 2, 2006; 27(6): 691 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Kreusser, M. Haass, S. J. Buss, S. E. Hardt, S. H. Gerber, R. Kinscherf, H. A. Katus, and J. Backs Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts Hypertension, February 1, 2006; 47(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Gould, M. Yii, M. D. Esler, J. M. Power, and D. M. Kaye Atrial fibrillation impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure Eur. Heart J., December 1, 2005; 26(23): 2562 - 2567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Floras Atrial fibrillation and cardiac sympathetic reflexes in heart failure Eur. Heart J., December 1, 2005; 26(23): 2490 - 2492. [Full Text] [PDF]
|
|
|
|
|
|
J. Spaak, Z. J. Egri, T. Kubo, E. Yu, S.-I. Ando, Y. Kaneko, K. Usui, T. D. Bradley, and J. S. Floras Muscle Sympathetic Nerve Activity During Wakefulness in Heart Failure Patients With and Without Sleep Apnea Hypertension, December 1, 2005; 46(6): 1327 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Bengel When the Heart Loses Its Nerves...and How Nuclear Imaging Helps to Understand J. Nucl. Med., August 1, 2005; 46(8): 1252 - 1253. [Full Text] [PDF]
|
|
|
|
|
|
M. Petersson, P. Friberg, G. Eisenhofer, G. Lambert, and B. Rundqvist Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure Eur. Heart J., May 1, 2005; 26(9): 906 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chowdhary, A. M. Marsh, J. H. Coote, and J. N. Townend Nitric Oxide and Cardiac Muscarinic Control in Humans Hypertension, May 1, 2004; 43(5): 1023 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Joles and H. A. Koomans Causes and Consequences of Increased Sympathetic Activity in Renal Disease Hypertension, April 1, 2004; 43(4): 699 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Sin and G. C. W. Man Cheyne-Stokes Respiration: A Consequence of a Broken Heart? Chest, November 1, 2003; 124(5): 1627 - 1628. [Full Text] [PDF]
|
|
|
|
|
|
H. P. Brunner-La Rocca Interaction of Angiotensin-Converting Enzyme Inhibition and Aspirin in Congestive Heart Failure: Long Controversy Finally Resolved? Chest, October 1, 2003; 124(4): 1192 - 1194. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Huke, L. H Liu, D. Biniakiewicz, W. T Abraham, and M. Periasamy Altered force-frequency response in non-failing hearts with decreased SERCA pump-level Cardiovasc Res, September 1, 2003; 59(3): 668 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schalcher, H. Rickli, M. Brehm, D. Weilenmann, E. Oechslin, W. Kiowski, and H. P. Brunner-La Rocca Prolonged Oxygen Uptake Kinetics During Low-Intensity Exercise Are Related to Poor Prognosis in Patients With Mild-to-Moderate Congestive Heart Failure Chest, August 1, 2003; 124(2): 580 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.A. v. Zwieten Drug Treatment of Congestive Heart Failure Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 13 - 17. [Abstract] [PDF]
|
|
|
|
|
|
P.R. Kalra, P.P. Ponikowski, and S.D. Anker Sympathetic activation and malignant ventricular arrhythmias: a molecular link? Eur. Heart J., July 2, 2002; 23(14): 1078 - 1080. [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, G. Bertinieri, M. L. Stella, C. Turri, and G. Mancia Sympathetic Response to Ventricular Extrasystolic Beats in Hypertension and Heart Failure Hypertension, April 1, 2002; 39(4): 886 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.J.S. Coats A sympathetic heart and the art of dying Eur. Heart J., July 1, 2001; 22(13): 1069 - 1071. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||